Combination therapy with long-acting  -agonists plus inhaled corticosteroids is no more effective than LABA monotherapy for mortality outcomes and severe exacerbations in moderate to very severe COPD and is associated with serious adverse effects

2010 ◽  
Vol 15 (3) ◽  
pp. 78-79
Author(s):  
P. A. Frith
CHEST Journal ◽  
2009 ◽  
Vol 136 (4) ◽  
pp. 1095-1100 ◽  
Author(s):  
Judith L. Black ◽  
Brian G.G. Oliver ◽  
Michael Roth

Sign in / Sign up

Export Citation Format

Share Document